Beta Bionics, Inc. (BBNX)
16.73
-0.85
(-4.84%)
USD |
NASDAQ |
Oct 30, 16:00
16.73
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Free Cash Flow : -65.96M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -65.96M |
| June 30, 2026 | -61.41M |
| March 31, 2026 | -61.12M |
| December 31, 2025 | -56.22M |
| September 30, 2025 | -60.53M |
| Date | Value |
|---|---|
| June 30, 2025 | -62.06M |
| March 31, 2025 | -59.43M |
| December 31, 2024 | -51.67M |
| September 30, 2024 | -43.49M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| PROCEPT BioRobotics Corp. | -84.92M |
| Edwards Lifesciences Corp. | 1.434B |
| Intuitive Surgical, Inc. | 3.598B |
| Stryker Corp. | 4.702B |
| Zimmer Biomet Holdings, Inc. | 1.079B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.29M |
| Cash from Investing (Quarterly) | -114.08M |
| Cash from Financing (Quarterly) | 163.60M |
| Free Cash Flow Per Share (Quarterly) | -0.3129 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.56M |
| Free Cash Flow Yield | -8.78% |